Opinion
26 August 2025
India’s Medtech Weak Spot Could Undermine Its Healthcare Leap
Without deeper manufacturing, pricing reform, and workforce investment, India risks dependency on imported medical technologies
Shailender Kumar Hooda is an Associate Professor at the Institute for Studies in Industrial Development (ISID).
SDG 9: Industry, Innovation and Infrastructure | SDG 3: Good Health and Well-being
Department of Pharmaceuticals DoPs | Department for Promotion of Industry And Internal Trade DPIIT
The discussion in this article is based on his working paper on the subject. Views are personal.
